JPS4852913A - - Google Patents

Info

Publication number
JPS4852913A
JPS4852913A JP47028889A JP2888972A JPS4852913A JP S4852913 A JPS4852913 A JP S4852913A JP 47028889 A JP47028889 A JP 47028889A JP 2888972 A JP2888972 A JP 2888972A JP S4852913 A JPS4852913 A JP S4852913A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP47028889A
Other languages
Japanese (ja)
Other versions
JPS5713522B2 (enExample
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4852913A publication Critical patent/JPS4852913A/ja
Publication of JPS5713522B2 publication Critical patent/JPS5713522B2/ja
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2888972A 1971-03-22 1972-03-22 Expired JPS5713522B2 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12702471A 1971-03-22 1971-03-22

Publications (2)

Publication Number Publication Date
JPS4852913A true JPS4852913A (enExample) 1973-07-25
JPS5713522B2 JPS5713522B2 (enExample) 1982-03-17

Family

ID=22427933

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2888972A Expired JPS5713522B2 (enExample) 1971-03-22 1972-03-22

Country Status (10)

Country Link
US (1) US3758680A (enExample)
JP (1) JPS5713522B2 (enExample)
AU (1) AU462695B2 (enExample)
CA (1) CA983391A (enExample)
DE (1) DE2213957A1 (enExample)
ES (1) ES401083A1 (enExample)
FR (1) FR2130559B1 (enExample)
GB (1) GB1338541A (enExample)
IT (1) IT1043890B (enExample)
ZA (1) ZA718319B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
CN109568282A (zh) * 2018-12-28 2019-04-05 河北威远动物药业有限公司 一种含乙酰氨基阿维菌素的瘤胃缓释片剂及制备方法

Also Published As

Publication number Publication date
IT1043890B (it) 1980-02-29
ZA718319B (en) 1972-09-27
AU3689071A (en) 1973-06-21
FR2130559A1 (enExample) 1972-11-03
GB1338541A (en) 1973-11-28
ES401083A1 (es) 1975-10-01
CA983391A (en) 1976-02-10
FR2130559B1 (enExample) 1975-06-20
JPS5713522B2 (enExample) 1982-03-17
US3758680A (en) 1973-09-11
DE2213957A1 (de) 1972-09-28
AU462695B2 (en) 1975-07-03

Similar Documents

Publication Publication Date Title
CS160056B2 (enExample)
CS163475B1 (enExample)
CS173591B2 (enExample)
CS172478B1 (enExample)
CS159900B1 (enExample)
CS157910B1 (enExample)
CS164385B1 (enExample)
CU33589A (enExample)
CS162810B1 (enExample)
CS161788B2 (enExample)
CS160257B1 (enExample)
CS161260B1 (enExample)
CS160996B1 (enExample)
CS161250B1 (enExample)
CS156851B1 (enExample)
CS174959B1 (enExample)
CS157235B1 (enExample)
CS157221B1 (enExample)
CS156870B1 (enExample)
CS148258B1 (enExample)
CS149399B1 (enExample)
CS149522B1 (enExample)
CS149912B2 (enExample)
CS150872B1 (enExample)
CS151121B1 (enExample)